Apeloa Pharmaceutical Co.,Ltd (SHE:000739)

SHE:000739 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	3,662	3,581	3,553	2,610	2,194
Trading Asset Securities	-	-	0.09	14.89	116.22
Cash & Short-Term Investments	3,662	3,581	3,553	2,625	2,310
Cash Growth	2.26%	0.78%	35.35%	13.61%	54.06%
Accounts Receivable	2,265	2,243	2,040	1,523	1,256
Other Receivables	112.26	114.46	116.28	103.74	61.54
Receivables	2,433	2,421	2,156	1,626	1,318
Inventory	1,860	2,083	1,802	1,250	1,086
Prepaid Expenses	4.64	26.65	20.59	13.06	16.04
Other Current Assets	227.8	256.96	249.5	267.72	187.1
Total Current Assets	8,187	8,368	7,781	5,782	4,917
Property, Plant & Equipment	3,775	3,564	3,406	2,588	1,981
Long-Term Investments	139.66	174.05	91.41	81.25	121.74
Goodwill	20.31	20.31	20.31	20.31	20.31
Other Intangible Assets	314.61	319.8	338.93	346.05	339.9
Long-Term Deferred Tax Assets	227.66	247.4	270.29	47.58	39.57
Long-Term Deferred Charges	15.77	20.57	66.21	46.76	11.96
Other Long-Term Assets	49.32	53.75	47.15	133.22	62.69
Total Assets	12,729	12,768	12,021	9,045	7,495
Accounts Payable	3,633	4,127	4,311	2,623	1,929
Accrued Expenses	251.62	226.43	202.82	221.62	249.4
Short-Term Debt	814.03	807.8	562.81	332.47	330.28
Current Portion of Long-Term Debt	5	81.34	0.4	0.2	-
Current Portion of Leases	6.61	7.98	8.65	13.77	-
Current Income Taxes Payable	92.33	77.04	80.59	120.56	131.04
Current Unearned Revenue	514.33	430.37	458.26	302.4	136.19
Other Current Liabilities	425.26	550.05	402.44	165.8	120.88
Total Current Liabilities	5,743	6,308	6,027	3,779	2,896
Long-Term Debt	70.05	18.71	249.62	104.94	-
Long-Term Leases	13.78	4.47	15.81	22.95	-
Long-Term Unearned Revenue	31.69	30.62	15.12	1.17	125.43
Long-Term Deferred Tax Liabilities	84.98	103.71	122.96	4.25	10.22
Other Long-Term Liabilities	36	72	72	72	72
Total Liabilities	5,979	6,537	6,502	3,985	3,104
Common Stock	1,169	1,179	1,179	1,179	1,179
Additional Paid-In Capital	247	438.01	438.01	438.01	438.01
Retained Earnings	5,481	4,804	4,096	3,443	2,774
Treasury Stock	-153.09	-200.2	-200.2	-	-
Comprehensive Income & Other	-2.02	2.01	-0.79	0.43	0.27
Total Common Equity	6,742	6,223	5,512	5,060	4,391
Minority Interest	7.92	7.69	7.35	-	-
Shareholders' Equity	6,750	6,230	5,519	5,060	4,391
Total Liabilities & Equity	12,729	12,768	12,021	9,045	7,495
Total Debt	909.47	920.3	837.3	474.33	330.28
Net Cash (Debt)	2,752	2,660	2,716	2,151	1,980
Net Cash Growth	3.45%	-2.04%	26.27%	8.61%	36.59%
Net Cash Per Share	2.37	2.28	2.31	1.82	1.68
Filing Date Shares Outstanding	1,158	1,169	1,169	1,179	1,179
Total Common Shares Outstanding	1,158	1,169	1,169	1,179	1,179
Working Capital	2,444	2,060	1,755	2,003	2,021
Book Value Per Share	5.82	5.32	4.71	4.29	3.73
Tangible Book Value	6,407	5,883	5,153	4,694	4,030
Tangible Book Value Per Share	5.53	5.03	4.41	3.98	3.42
Buildings	1,991	1,743	1,743	1,474	1,456
Machinery	4,767	4,398	4,126	2,903	2,755
Construction In Progress	407.48	545.85	311.4	710.22	158.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.